{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T04:14:41Z","timestamp":1783138481423,"version":"3.54.6"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jns.2021.120021","type":"journal-article","created":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T04:46:08Z","timestamp":1633149968000},"page":"120021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Parkinsonism and motor neuron disorders: Lessons from Western Pacific ALS\/PDC"],"prefix":"10.1016","volume":"433","author":[{"given":"Peter S.","family":"Spencer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"419","key":"10.1016\/j.jns.2021.120021_bb0005","doi-asserted-by":"crossref","first-page":"117185","DOI":"10.1016\/j.jns.2020.117185","article-title":"Western Pacific ALS-PDC: Evidence implicating cycad genotoxins","volume":"15","author":"Spencer","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2021.120021_bb0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1751143717709420","article-title":"The life and work of Jean-Martin Charcot (1825-1893): 'The Napoleon of Neuroses'","volume":"19","author":"Waraich","year":"2018","journal-title":"J. Intensive Care Soc."},{"key":"10.1016\/j.jns.2021.120021_bb0015","first-page":"291","article-title":"Degeneration of the substantia nigra in familial amyotrophic lateral sclerosis","volume":"10","author":"Wolf","year":"1991","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.jns.2021.120021_bb0020","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1365-2990.1993.tb00444.x","article-title":"Diminution of dopaminergic neurons in the substantia nigra of sporadic amyotrophic lateral sclerosis","volume":"19","author":"Kato","year":"1993","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.jns.2021.120021_bb0025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF00309344","article-title":"Parkinsonism in motor neuron disease: case report and literature review","volume":"89","author":"Williams","year":"1995","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jns.2021.120021_bb0030","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/archneur.1996.00550100061015","article-title":"Motor neuron disease with parkinsonism","volume":"53","author":"Qureshi","year":"1996","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2021.120021_bb0035","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/jnnp.65.2.263","article-title":"Dopaminergic deficit in amyotrophic lateral sclerosis assessed with [I-123] IPT single photon emission computed tomography","volume":"65","author":"Borasio","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2021.120021_bb0040","first-page":"293","article-title":"Nigral degeneration in a case of amyotrophic lateral sclerosis: evidence of Lewy body-like and skein-like inclusions in the pigmented neurons","volume":"18","author":"Su","year":"1999","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.jns.2021.120021_bb0045","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/mds.20604","article-title":"Alpha-synuclein immunohistochemistry in two cases of co-occurring idiopathic Parkinson's disease and motor neuron disease","volume":"20","author":"Klos","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2021.120021_bb0050","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1440-1789.2007.00763.x","article-title":"Amyotrophic lateral sclerosis with dementia showing clinical parkinsonism and severe degeneration of the substantia nigra: report of an autopsy case","volume":"27","author":"Shintaku","year":"2007","journal-title":"Neuropathology."},{"key":"10.1016\/j.jns.2021.120021_bb0055","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1002\/mds.22762","article-title":"Extrapyramidal stiffness in patients with amyotrophic lateral sclerosis","volume":"24","author":"Pradat","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2021.120021_bb0060","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s10072-012-1139-1","article-title":"Clinical and neuroimaging characteristics in neurodegenerative overlap syndrome","volume":"34","author":"Lim","year":"2013","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jns.2021.120021_bb0065","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jns.2014.07.022","article-title":"ALS-plus syndrome: non-pyramidal features in a large ALS cohort","volume":"345","author":"McCluskey","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2021.120021_bb0070","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/neup.12606","article-title":"Phenotypic variability and its pathological basis in amyotrophic lateral sclerosis","volume":"40","author":"Takeda","year":"2020","journal-title":"Neuropathology."},{"key":"10.1016\/j.jns.2021.120021_bb0075","doi-asserted-by":"crossref","DOI":"10.1111\/ene.14849","article-title":"Coexisting Lewy body disease and clinical parkinsonism in amyotrophic lateral sclerosis","author":"Forrest","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2021.120021_bb0080","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/17482968.2011.603732","article-title":"Parkinson-like features in ALS with predominant upper motor neuron involvement","volume":"13","author":"D'Ascenzo","year":"2012","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.jns.2021.120021_bb0085","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s00415-019-09305-0","article-title":"Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study","volume":"266","author":"Calvo","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2021.120021_bb0090","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/s-2001-15263","article-title":"Atypical motor neuron disease and related motor syndromes","volume":"21","author":"Verma","year":"2001","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.jns.2021.120021_bb0095","first-page":"1013","article-title":"Phenotypes in ALS--clinical features and pathology","volume":"59","author":"Sasaki","year":"2007","journal-title":"Brain Nerve"},{"key":"10.1016\/j.jns.2021.120021_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00207454.2011.613551","article-title":"Involvement of the spinal cord in Parkinson's disease","volume":"122","author":"Raudino","year":"2012","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.jns.2021.120021_bb0105","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00401-012-1028-y","article-title":"Spinal cord lesions in sporadic Parkinson's disease","volume":"124","author":"Del Tredici","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jns.2021.120021_bb0110","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ana.410410312","article-title":"Pathological correlates of extrapyramidal signs in Alzheimer\u2019s disease","volume":"41","author":"Liu","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2021.120021_bb0115","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00401-003-0725-y","article-title":"Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study","volume":"106","author":"Jellinger","year":"2003","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jns.2021.120021_bb0120","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1212\/01.WNL.0000158423.05224.7F","article-title":"The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs","volume":"64","author":"Burns","year":"2005","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2021.120021_bb0125","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/archneurol.2009.196","article-title":"Extrapyramidal signs before and after diagnosis of incident Alzheimer disease in a prospective population study","volume":"66","author":"Portet","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2021.120021_bb0130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/bs.irn.2019.10.012","article-title":"Parkinsonism in frontotemporal dementias","volume":"149","author":"Rowe","year":"2019","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.jns.2021.120021_bb0135","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/jnnp.2009.201608","article-title":"Rapidly progressive atypical parkinsonism associated with frontotemporal lobar degeneration and motor neuron disease","volume":"82","author":"Espay","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2021.120021_bb0140","doi-asserted-by":"crossref","first-page":"a024117","DOI":"10.1101\/cshperspect.a024117","article-title":"Clinical spectrum of amyotrophic lateral sclerosis (ALS)","volume":"7","author":"Grad","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.jns.2021.120021_bb0145","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: a clinical review","volume":"27","author":"Masrori","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2021.120021_bb0150","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ncl.2015.07.012","article-title":"Neuropathology of amyotrophic lateral sclerosis and Its variants","volume":"33","author":"Saberi","year":"2015","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.jns.2021.120021_bb0155","first-page":"1152","article-title":"Neuropathology of amyotrophic lateral sclerosis","volume":"71","author":"Yoshida","year":"2019","journal-title":"Brain Nerve"},{"issue":"suppl 2","key":"10.1016\/j.jns.2021.120021_bb0160","article-title":"SOD1 aggregation: A pathological link between Parkinson\u2019s disease and amyotrophic lateral sclerosis? [abstract]","volume":"31","author":"Trist","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2021.120021_bb0165","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1468-1331.2008.02513.x","article-title":"Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options","volume":"16","author":"Ludolph","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2021.120021_bb0170","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000433581","article-title":"An assessment of possible neuropathology and clinical relationships in 46 sporadic amyotrophic lateral sclerosis patient autopsies","volume":"15","author":"Coan","year":"2015","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.jns.2021.120021_bb0175","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/1073858408319974","article-title":"Etiopathogenesis of Parkinson disease: a new beginning?","volume":"15","author":"Le","year":"2009","journal-title":"Neuroscientist."},{"key":"10.1016\/j.jns.2021.120021_bb0180","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1001\/archneurol.2010.321","article-title":"Preclinical markers of Parkinson disease","volume":"68","author":"Wu","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2021.120021_bb0185","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1136\/jnnp-2013-307135","article-title":"Amyotrophic lateral sclerosis: a long preclinical period?","volume":"85","author":"Eisen","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2021.120021_bb0190","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","article-title":"Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria","volume":"12","author":"Dubois","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jns.2021.120021_bb0195","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/EB.S260823","article-title":"Etiology of retinal and cerebellar pathology in Western Pacific amyotrophic lateral sclerosis and parkinsonism-dementia complex","volume":"12","author":"Spencer","year":"2020","journal-title":"Eye Brain."},{"key":"10.1016\/j.jns.2021.120021_bb0200","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1212\/WNL.5.4.249","article-title":"Epidemiologic investigations of amyotrophic lateral sclerosis: Familial aggregations indicative of dominant inheritance I and II","volume":"5","author":"Kurland","year":"1955","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2021.120021_bb0205","first-page":"617","article-title":"Amyotrophic lateral sclerosis-Parkinsonism-dementia complex of Guam IV. Familial and genetic investigations","volume":"19","author":"Plato","year":"1967","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jns.2021.120021_bb0210","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/oxfordjournals.aje.a112098","article-title":"Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam, 1945\u20131972. II. Familial and genetic studies","volume":"101","author":"Reed","year":"1975","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jns.2021.120021_bb0215","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ana.410130117","article-title":"Epidemiological surveillance of amyotrophic lateral sclerosis and parkinsonism-dementia in the Commonwealth of the Northern Mariana Islands","volume":"13","author":"Yanagihara","year":"1983","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2021.120021_bb0220","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/oxfordjournals.aje.a114437","article-title":"Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam: a 25-year prospective case-control study","volume":"124","author":"Plato","year":"1986","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jns.2021.120021_bb0225","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/aje\/kwf175","article-title":"Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years","volume":"157","author":"Plato","year":"2003","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jns.2021.120021_bb0230","first-page":"1065","article-title":"Revisit to Kii ALS--the innovated concept of ALS-Parkinsonism-dementia complex, clinicopathological features, epidemiology and etiology","volume":"59","author":"Kuzuhara","year":"2007","journal-title":"Brain Nerve."},{"key":"10.1016\/j.jns.2021.120021_bb0235","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1002\/mds.22262","article-title":"Mutation analyses in amyotrophic lateral sclerosis\/parkinsonism-dementia complex of the Kii peninsula","volume":"23","author":"Tomiyama","year":"2008","journal-title":"Japan Mov. Disord."},{"key":"10.1016\/j.jns.2021.120021_bb0240","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/aje\/kwf175","article-title":"Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years","volume":"157","author":"Plato","year":"2003","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jns.2021.120021_bb0245","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1212\/01.wnl.0000262028.16738.64","article-title":"Prevalence of dementia in Chamorros on Guam: relationship to age, gender, education, and APOE","volume":"68","author":"Galasko","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2021.120021_bb0250","series-title":"Amyotrophic Lateral Sclerosis and the Frontotemporal Dementias, Chapter 3","first-page":"39","article-title":"Amyotrophic lateral sclerosis-parkinsonism-dementia complex in the Kii peninsula of Japan (Muro disease): A review of recent research and new concept","author":"Kuzuhara","year":"2012"},{"key":"10.1016\/j.jns.2021.120021_bb0255","first-page":"369","article-title":"Amyotrophic lateral sclerosis in the Kii Peninsula of Japan, 1987\u20131991, A migration study","volume":"41","author":"Yoshida","year":"1994","journal-title":"Shinkeinaika"},{"key":"10.1016\/j.jns.2021.120021_bb0260","first-page":"187","article-title":"Epidemiological and clinical patterns of western pacific amyotrophic lateral sclerosis (ALS) in Guam and sporadic ALS in Rochester, Minnesota, U.S.A. and Hokkaido, Japan: a comparative study","volume":"78","author":"Okumura","year":"2003","journal-title":"Hokkaido Igaky Zasshi"},{"key":"10.1016\/j.jns.2021.120021_bb0265","first-page":"1549","article-title":"Disappearance of ALS from Guam: implications for exogenous causes","volume":"35","author":"Chen","year":"1995","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.jns.2021.120021_bb0270","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1002\/mds.20552","article-title":"On the decline and etiology of high-incidence motor system disease in West Papua (Southwest New Guinea)","volume":"12","author":"Spencer","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2021.120021_bb0275","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004353","article-title":"Amyotrophic lateral sclerosis and parkinsonism in Papua, Indonesia: 2001-2012 survey results","volume":"4","author":"Okumiya","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.jns.2021.120021_bb0280","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00401-008-0439-2","article-title":"Enduring involvement of tau, beta-amyloid, alpha-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis\/parkinsonism-dementia complex of Guam (ALS\/PDC)","volume":"116","author":"Miklossy","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jns.2021.120021_bb0285","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/neup.12434","article-title":"Amyotrophic lateral sclerosis and parkinsonism-dementia complex of the Hohara focus of the Kii Peninsula: A multiple proteinopathy?","volume":"38","author":"Mimuro","year":"2018","journal-title":"Neuropathology"},{"issue":"Suppl. 2","key":"10.1016\/j.jns.2021.120021_bb0290","doi-asserted-by":"crossref","first-page":"II19","DOI":"10.1007\/BF03161078","article-title":"Neuropathology of parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam: an update","volume":"246","author":"Oyanagi","year":"1999","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2021.120021_bb0295","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00401-007-0257-y","article-title":"Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam","volume":"115","author":"Geser","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jns.2021.120021_bb0300","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00401-004-0840-4","article-title":"Occurrence of alpha-synuclein pathology in the cerebellum of Guamanian patients with parkinsonism-dementia complex","volume":"107","author":"Sebeo","year":"2004","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jns.2021.120021_bb0305","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/bpa.12500","article-title":"Unusual tau pathology of the cerebellum in patients with amyotrophic lateral sclerosis\/parkinsonism-dementia complex from the Kii peninsula, Japan","volume":"29","author":"Morimoto","year":"2018","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jns.2021.120021_bb0310","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00401-006-0053-0","article-title":"Characterization of tau pathologies in gray and white matter of Guam parkinsonism-dementia complex","volume":"111","author":"Winton","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jns.2021.120021_bb0315","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.aan3842","article-title":"A Neolithic expansion, but strong genetic structure, in the independent history of New Guinea","volume":"357","author":"Bergstr\u00f6m","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jns.2021.120021_bb0320","first-page":"1","article-title":"Japan considered from the hypothesis of farmer\/language spread","volume":"e13","author":"de Boe","year":"2020","journal-title":"Evol. Hum. Sci"},{"key":"10.1016\/j.jns.2021.120021_bb0325","first-page":"1","article-title":"Lytico-bodig in Guam: Historical links between diet and illness during and after Spanish colonization","author":"Gim\u00e9nez-Rold\u00e1n","year":"2021","journal-title":"J. Hist. Neurosci."},{"key":"10.1016\/j.jns.2021.120021_bb0330","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1212\/WNL.53.2.411","article-title":"Neurodegenerative diseases of Guam: analysis of TAU","volume":"53","author":"P\u00e9rez-Tur","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2021.120021_bb0335","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1001\/archneur.58.11.1871","article-title":"TAU as a susceptibility gene for amyotropic lateral sclerosis-parkinsonism dementia complex of Guam","volume":"58","author":"Poorkaj","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2021.120021_bb0340","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/jamaneurol.2013.1817","article-title":"C9orf72 hexanucleotide repeat expansion and Guam amyotrophic lateral sclerosis-parkinsonism-dementia complex","volume":"70","author":"Dombroski","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jns.2021.120021_bb0345","first-page":"59","article-title":"Familial amyotrophic lateral sclerosis and parkinsonism-dementia complex\u2013tauopathy without mutations in the tau gene?","volume":"41","author":"Kowalska","year":"2003","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.jns.2021.120021_bb0350","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/archneur.61.12.1889","article-title":"Genome-wide analysis of the parkinsonism dementia complex of Guam","volume":"61","author":"Morris","year":"2004","journal-title":"Arch. Neurol."},{"issue":"Suppl. 12","key":"10.1016\/j.jns.2021.120021_bb0355","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1002\/mds.20548","article-title":"Atypical parkinsonism of Japan: amyotrophic lateral sclerosis-parkinsonism-dementia complex of the Kii peninsula of Japan (Muro disease): an update","volume":"20","author":"Kuzuhara","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2021.120021_bb0360","doi-asserted-by":"crossref","first-page":"11510","DOI":"10.1073\/pnas.0505149102","article-title":"A TRPM7 variant shows altered sensitivity to magnesium that may contribute to the pathogenesis of two Guamanian neurodegenerative disorders","volume":"102","author":"Hermosura","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jns.2021.120021_bb0365","doi-asserted-by":"crossref","first-page":"18029","DOI":"10.1073\/pnas.0808218105","article-title":"Altered functional properties of a TRPM2 variant in Guamanian ALS and PD","volume":"105","author":"Hermosura","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jns.2021.120021_bb0370","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/hmg\/ddl463","article-title":"Two sites in the MAPT region confer genetic risk for Guam ALS\/PDC and dementia","volume":"16","author":"Sundar","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jns.2021.120021_bb0375","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1093\/hmg\/ddp300","article-title":"Identification of novel susceptibility loci for Guam neurodegenerative disease: challenges of genome scans in genetic isolates","volume":"18","author":"Sieh","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jns.2021.120021_bb0380","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archneurol.2009.328","article-title":"The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration","volume":"67","author":"Yu","year":"2010","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.jns.2021.120021_bb0385","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ajmg.b.30966","article-title":"TRPM7 is not associated with amyotrophic lateral sclerosis-parkinsonism dementia complex in the Kii peninsula of Japan","volume":"153B","author":"Hara","year":"2010","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.jns.2021.120021_bb0390","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s10072-011-0735-9","article-title":"Inherited and somatic mitochondrial DNA mutations in Guam amyotrophic lateral sclerosis and parkinsonism-dementia","volume":"32","author":"Reiff","year":"2011","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jns.2021.120021_bb0395","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/archneurol.2012.1219","article-title":"C9ORF72 repeat expansion in amyotrophic lateral sclerosis in the Kii peninsula of Japan","volume":"69","author":"Ishiura","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2021.120021_bb0400","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ana.24346","article-title":"Defining neurodegeneration on Guam by targeted genomic sequencing","volume":"77","author":"Steele","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2021.120021_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2012.05.011","article-title":"Japanese Consortium for Amyotrophic Lateral Sclerosis research (JaCALS). Analysis of C9orf72 repeat expansion in 563 Japanese patients with amyotrophic lateral sclerosis","volume":"33","author":"Ogaki","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jns.2021.120021_bb0410","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3109\/17482968.2012.684213","article-title":"Mutational analysis of familial and sporadic amyotrophic lateral sclerosis with OPTN mutations in Japanese population","volume":"13","author":"Naruse","year":"2012","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.jns.2021.120021_bb0415","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/bpa.12558","article-title":"Optineurin pathology in the spinal cord of amyotrophic lateral sclerosis\/parkinsonism-dementia complex patients in Kii peninsula Japan","volume":"28","author":"Morimoto","year":"2018","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jns.2021.120021_bb0420","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ana.410100405","article-title":"Amyotrophic lateral sclerosis and parkinsonism-dementia among Filipino migrants to Guam","volume":"10","author":"Garruto","year":"1981","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2021.120021_bb0425","series-title":"The Search for a Cause. An Anthropological Perspective on a Neurological Disease in Guam, Western Pacific","author":"Keck","year":"2012"},{"key":"10.1016\/j.jns.2021.120021_bb0430","series-title":"Center for Research on the Occupational and Environmental Toxicology 2002","first-page":"37","article-title":"Preliminary Study of Possible Risk Factors for Amyotrophic Sclerosis in Gulf War and Gulf Era Veterans, Report to U.S. Department of Veterans Affairs, Washington DC","author":"Palmer","year":"2002"},{"key":"10.1016\/j.jns.2021.120021_bb0435","series-title":"Discussing a Genetic Etiology, in 5th Controversies in Neurology, Beijing, October 13\u201316","article-title":"Western Pacific ALS-Parkinsonism dementia complex: genetic or toxic etiology","author":"Steele","year":"2011"},{"key":"10.1016\/j.jns.2021.120021_bb0440","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.neuro.2016.03.017","article-title":"Seeking environmental causes of neurodegenerative disease and envisioning primary prevention","volume":"56","author":"Spencer","year":"2016","journal-title":"Neurotoxicology."},{"key":"10.1016\/j.jns.2021.120021_bb0445","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1093\/brain\/124.11.2215","article-title":"A clinical and pathological study of motor neurone disease on Guam","volume":"124","author":"Morris","year":"2001","journal-title":"Brain."},{"key":"10.1016\/j.jns.2021.120021_bb0450","series-title":"Behavioral Measures of Neurotoxicity National Academy Press, Washington, D.C","first-page":"11","article-title":"Are neurotoxins driving us crazy? Planetary observations on the causes of neurodegenerative diseases of old age","author":"Spencer","year":"1990"},{"key":"10.1016\/j.jns.2021.120021_bb0455","author":"BBC"},{"key":"10.1016\/j.jns.2021.120021_bb0460","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1212\/01.wnl.0000262027.31623.b2","article-title":"Cycad exposure and risk of dementia, MCI, and PDC in the Chamorro population of Guam","volume":"68","author":"Borenstein","year":"2007","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2021.120021_bb0465","doi-asserted-by":"crossref","first-page":"100230","DOI":"10.1016\/j.ensci.2020.100230","article-title":"Kamp\u014d medicine and Muro disease (Amyotrophic Lateral Sclerosis and Parkinsonism-Dementia Complex)","volume":"18","author":"Spencer","year":"2020","journal-title":"eNeurologicalSci"},{"key":"10.1016\/j.jns.2021.120021_bb0470","doi-asserted-by":"crossref","first-page":"100308","DOI":"10.1016\/j.ensci.2020.100308","article-title":"Kamp\u014d medicine and Muro disease (amyotrophic lateral sclerosis and parkinsonism-dementia complex): Postscript and historical footnote","volume":"22","author":"Spencer","year":"2021","journal-title":"eNeurologicalSci"},{"key":"10.1016\/j.jns.2021.120021_bb0475","series-title":"Handbook of neurotoxicity","article-title":"Mechanisms underlying long-latency neurodegenerative disease of environmental origin","volume":"Vol. 4","author":"Spencer","year":"2021"},{"key":"10.1016\/j.jns.2021.120021_bb0480","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/exnr.1998.6962","article-title":"The Guam cycad toxin methylazoxymethanol damages neuronal DNA and modulates tau mRNA expression and excitotoxicity","volume":"155","author":"Esclaire","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jns.2021.120021_bb0485","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1021\/pr060126g","article-title":"Proteomic analysis of the genotoxicant methylazoxymethanol (MAM)-induced changes in the developing cerebellum","volume":"5","author":"Kisby","year":"2006","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jns.2021.120021_bb0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-3806(84)90134-2","article-title":"Pervasive hyperactivity and long-term learning impairments in rats with induced micrencephaly from prenatal exposure to methylazoxymethanol","volume":"317","author":"Vorhees","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.jns.2021.120021_bb0495","first-page":"699","article-title":"Methylazoxymethanol acetate (MAM ac) effects on the ontogenesis of the mouse neocortex","volume":"30","author":"Ciaroni","year":"1989","journal-title":"J. Hirnforsch."},{"key":"10.1016\/j.jns.2021.120021_bb0500","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0892-0362(92)90048-F","article-title":"Premature decline in Morris water maze performance of aging micrencephalic rats","volume":"14","author":"Lee","year":"1992","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.jns.2021.120021_bb0505","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/jnen\/nlab006","article-title":"Cycad genotoxin methylazoxymethanol disrupts the brain ubiquitin-proteasome pathway, tau and \u03b1-synuclein, as reported in ALS-PDC","volume":"80","author":"Kisby","year":"2021","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jns.2021.120021_bb0510","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/toxins10010022","article-title":"A single neonatal exposure to BMAA in a rat model produces neuropathology consistent with neurodegenerative diseases","volume":"10","author":"Scott","year":"2018","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.jns.2021.120021_bb0515","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1126\/science.3603037","article-title":"Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin","volume":"237","author":"Spencer","year":"1987","journal-title":"Science."},{"key":"10.1016\/j.jns.2021.120021_bb0520","first-page":"20152397","article-title":"Dietary exposure to an environmental toxin triggers neurofibrillary tangles and amyloid deposits in the brain","volume":"283","author":"Cox","year":"2016","journal-title":"Proc. Biol. Sci."},{"key":"10.1016\/j.jns.2021.120021_bb0525","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/jnen\/nlaa002","article-title":"l-Serine reduces spinal cord pathology in a vervet model of preclinical ALS\/MND","volume":"79","author":"Davis","year":"2020","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jns.2021.120021_bb0530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020911","article-title":"The cycad genotoxin MAM modulates brain cellular pathways involved in neurodegenerative disease and cancer in a DNA damage-linked manner","volume":"6","author":"Kisby","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2021.120021_bb0535","series-title":"ALS: New Advances in Toxicology and Epidemiology","first-page":"35","article-title":"Neurotoxic amino acids from the cycad carcinogen methylazoxymethanol","author":"Kisby","year":"1990"},{"key":"10.1016\/j.jns.2021.120021_bb0540","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1212\/WNL.42.7.1336","article-title":"Content of the neurotoxins cycasin (methylazoxymethanol beta-D-glucoside) and BMAA (beta-N-methylamino-L-alanine) in cycad flour prepared by Guam Chamorros","volume":"42","author":"Kisby","year":"1992","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2021.120021_bb0545","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/jnnp.61.2.131","article-title":"Neuroepidemiology of amyotrophic lateral sclerosis: clues to aetiology and pathogenesis","volume":"61","author":"Rom\u00e1n","year":"1996","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2021.120021_bb0550","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fgene.2012.00192","article-title":"Unraveling 50-year-old clues linking neurodegeneration and cancer to cycad toxins: are microRNAs common mediators?","volume":"3","author":"Spencer","year":"2012","journal-title":"Front. Genet."},{"key":"10.1016\/j.jns.2021.120021_bb0555","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s10654-017-0249-8","article-title":"Occupational formaldehyde and amyotrophic lateral sclerosis","volume":"32","author":"Seals","year":"2017","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.jns.2021.120021_bb0560","doi-asserted-by":"crossref","DOI":"10.1007\/s12640-020-00320-y","article-title":"Formaldehyde and brain disorders: a meta-analysis and bioinformatics approach","author":"Rana","year":"2021","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.jns.2021.120021_bb0565","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neurobiolaging.2014.07.018","article-title":"Age-related formaldehyde interferes with DNA methyltransferase function, causing memory loss in Alzheimer\u2019s disease","volume":"36","author":"Tong","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jns.2021.120021_bb0570","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s42003-019-0694-x","article-title":"Endogenous formaldehyde is a memory-related molecule in mice and humans","volume":"2","author":"Ai","year":"2019","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jns.2021.120021_bb0575","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0022-510X(97)00300-6","article-title":"Epidemiology of motor neuron disease in the Kii Peninsula of Japan, 1989\u20131993: Active or disappearing focus?","volume":"155","author":"Yoshida","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2021.120021_bb0580","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jocn.2017.08.057","article-title":"A migration case of Kii amyotrophic lateral sclerosis\/parkinsonism dementia complex with the shortest stay in the endemic area and the longest incubation to develop the disease","volume":"46","author":"Tsunoda","year":"2017","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jns.2021.120021_bb0585","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/17482960701553956","article-title":"Young-onset sporadic amyotrophic lateral sclerosis: a distinct nosological entity?","volume":"8","author":"Gouveia","year":"2007","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.jns.2021.120021_bb0590","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1212\/01.wnl.0000312378.94737.45","article-title":"Natural history of young-adult amyotrophic lateral sclerosis","volume":"71","author":"Sabatelli","year":"2008","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2021.120021_bb0595","first-page":"1","article-title":"X Yao, the distinct manifestation of young-onset amyotrophic lateral sclerosis in China","volume":"30","author":"Lin","year":"2020","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"10.1016\/j.jns.2021.120021_bb0600","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1001\/archneurol.2010.321","article-title":"Preclinical biomarkers of Parkinson disease","volume":"68","author":"Wu","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2021.120021_bb0605","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0140-6736(86)90469-1","article-title":"Alzheimer\u2019s disease, Parkinson\u2019s disease, and motoneurone disease: abiotrophic interaction between ageing and environment?","volume":"2","author":"Calne","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2021.120021_bb0610","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1874609811003010003","article-title":"DNA repair in premature aging disorders and neurodegeneration","volume":"3","author":"Copped\u00e8","year":"2010","journal-title":"Curr. Aging Sci."},{"key":"10.1016\/j.jns.2021.120021_bb0615","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1100\/2011\/853474","article-title":"An overview of DNA repair in amyotrophic lateral sclerosis","volume":"11","author":"Copped\u00e8","year":"2011","journal-title":"Sci. World J."},{"key":"10.1016\/j.jns.2021.120021_bb0620","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/nan.12533","volume":"45","author":"Spencer","year":"2019","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.jns.2021.120021_bb0625","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/nan.12465","article-title":"Review: somatic mutations in neurodegeneration","volume":"44","author":"Leija-Salazar","year":"2018","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.jns.2021.120021_bb0630","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1590\/S0004-282X2009000600015","article-title":"Conjugal amyotrophic lateral sclerosis in Brazil","volume":"67","author":"Godeiro","year":"2009","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.jns.2021.120021_bb0635","doi-asserted-by":"crossref","first-page":"8254","DOI":"10.1038\/s41598-019-44765-4","article-title":"Monozygotic twins and triplets discordant for amyotrophic lateral sclerosis display differential methylation and gene expression","volume":"9","author":"Tarr","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jns.2021.120021_bb0640","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.parkreldis.2009.09.002","article-title":"Conjugal parkinsonism and Parkinson disease: a case series with environmental risk factor analysis","volume":"16","author":"Willis","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2021.120021_bb0645","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archneur.60.4.553","article-title":"A clustering of conjugal amyotrophic lateral sclerosis in southeastern France","volume":"60","author":"Corcia","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2021.120021_bb0650","doi-asserted-by":"crossref","first-page":"117558","DOI":"10.1016\/j.jns.2021.117558","article-title":"An amyotrophic lateral sclerosis hot spot in the French Alps associated with genotoxic fungi","volume":"427","author":"Legrange","year":"2021","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2021.120021_bb0655","article-title":"Hypothesis: etiologic and molecular mechanistic leads for sporadic neurodegenerative diseases based on experience with Western Pacific ALS\/PDC","volume":"754","author":"Spencer","year":"2019","journal-title":"Front. Neurol."},{"issue":"5 Suppl 2","key":"10.1016\/j.jns.2021.120021_bb0660","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1212\/WNL.41.5_Suppl_2.62","article-title":"Slow toxins, biologic markers, and long-latency neurodegenerative disease in the western Pacific region","volume":"41","author":"Spencer","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2021.120021_bb0665","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1021\/acs.chemrestox.1c00150","article-title":"Role of hydrazine-related chemicals in cancer and neurodegenerative disease","volume":"34","author":"Spencer","year":"2021","journal-title":"Chem. Res Toxicol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21027179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21027179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:58:01Z","timestamp":1758383881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X21027179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":133,"alternative-id":["S0022510X21027179"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2021.120021","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parkinsonism and motor neuron disorders: Lessons from Western Pacific ALS\/PDC","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2021.120021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120021"}}